ABOUT / NEWS & MEDIA
News & Media
SpotItEarly Featured on Israel's Channel 12 (Mako)
Israeli news outlet Mako (Channel 12) aired a feature on SpotItEarly, showcasing how the company uses trained dogs and artificial intelligence to detect cancer early from breath samples. The televised segment included behind-the-scenes footage from the company’s training facility, along with interviews that explained the groundbreaking science and its real-world potential.
SpotItEarly's CEO, Shlomi Madar, at INBIA ICBI39 conference
SpotItEarly's CEO, Shlomi Madar, spoke at an INBIA ICBI39 conference in Philadelphia.
Shlomi shared SpotItEarly’s journey as an Israeli-American startup expanding into the U.S. market—and how programs like the U.S. Market Access Program helped us bridge unexpected gaps and thrive in a new ecosystem.
Annual Conference of the Israel Society for Clinical Laboratory Sciences
Our SVP of Operations, Amir Lifshitz, and Director of Canine Applied Research, Dr. Irit Gazit, recently presented at the Annual Conference of the Israel Society for Clinical Laboratory Sciences (ISCLS).
SpotitEarly joins the BIRD foundation panel in the Science center, Philadelphia
Penn Medicine’s Brian Englander and SpotItEarly’s Co-founder Udi Bobrovsky shared insights on their groundbreaking project, approved in December 2024, to develop an early cancer detection technology that combines AI with dogs’
SpotItEarly and Penn Medicine Receive BIRD Foundation Investment
SpotItEarly, in partnership with Penn Medicine, was awarded an investment from the BIRD Foundation. This collaboration aims to develop, test, and validate an early cancer detection technology that combines AI with dogs' highly sensitive sense of smell.
2025
Science News featured SpotItEarly in an in-depth article exploring how trained dogs, paired with artificial intelligence, are transforming the way cancer is detected. The article highlights SpotItEarly’s latest research, trial results, and the unique partnership between humans and dogs in medical innovation.
SpotItEarly's groundbreaking clinical research was published in Scientific Reports, a Nature journal. The peer reviewed study demonstrated that their unique bio-AI hybrid system using trained dogs and machine learning to analyze breath samples — achieved high sensitivity and specificity in detecting multiple early stage cancers.
.jpg)
SpotitEarly presented its innovative breath-based cancer screening approach at Fox Chase Cancer Center
The seminar detailed the bio-AI hybrid platform that combines trained canines and artificial intelligence, to detect multiple cancers, including breast, lung, prostate, and colorectal, from a single breath sample.
Clinical Lab Products highlighted SpotitEarly's novel cancer detection method, which combines AI with canine scent detection to identify cancer biomarkers in breath samples. The article emphasized the test's 95% sensitivity for early-stage cancers and its potential to revolutionize non-invasive cancer screening.
2024
.avif)
Dogs’ wondrous ability to detect disease has been documented since the late 1990s. Yet no ‘dog-test’ has ever been made accessible to the public. Now an Israeli startup suggests its technology may bridge the gap
Rise, Assuta Medical Centers’ innovation arm, named 10 startups that have been selected to participate in the second cohort of “RISE with US”.
NoCamels reported on SpotitEarly's impressive 92.8% accuracy rate in detecting breast, lung, colon, and prostate cancers using AI-assisted Labrador retrievers to analyze patients' breath samples.
2023
Each type of cancer has a unique odor, and most also have a common denominator. Dogs can detect these odors in a fraction of a second
SpotitEarly secured $6.2 million in seed funding to advance its innovative cancer detection technology, which leverages the olfactory abilities of trained dogs combined with artificial intelligence.
In August 2022, ISRAEL21c featured SpotItEarly’s revolutionary method of training Labrador retrievers to identify cancer through breath samples.
Israel’s Trade & Economic Mission to India highlighted SpotItEarly’s breath-based, multi-cancer screening technology. The method uses specially trained dogs and AI to detect cancer with high precision, non-invasively and cost-effectively.